| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Health In Tech, Inc.'s insiders have reduced their positions by a net 44,730 shares worth roughly $40K. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
Counted by filing, the last 12 months brought no open-market purchases and 4 sales by 2 insiders worth about $40K. There were none in the 12 months before that either.
2 of the 4 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
No open-market purchase by an insider appears in the HIT Form 4 filings on record.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 23.15M | $13.28M | - | |
| CEO | 8.92M | $5.12M | - | |
| CEO | 5.60M | $3.21M | - | |
| Other | 173.7K | $99.6K | -3,333 | |
| Dir | 164.8K | $94.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Zain Syed Hasan | Chief Growth Officer | Sell10b5-1 | 3,333 | $0.62 | $2,066.46 | -1.9% | - | - | |
| Sep 14, 2026 | Timothy Hayes | Director | Sell | 12,000 | $0.89 | $10,716.00 | -9.9% | - | - | |
| Sep 11, 2026 | Zain Syed Hasan | Chief Growth Officer | Sell10b5-1 | 11,667 | $0.92 | $10,733.64 | -5.8% | - | - | |
| Sep 11, 2026 | Timothy Hayes | Director | Sell | 17,730 | $0.92 | $16,248.90 | -12.8% | - | - |